Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 17, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2025. Go to the latest filing (Q3 2026)

61.1B USDQ4 2025
Total value of stock positions
61.1B USD
Positions
2,030
Share of the ten largest
16.6%

The ten largest positions Q4 2025

  1. Nvidia 3.0%▲ +37.9%
  2. Taiwan Semiconductor Manufacturing (ADR) 2.3%▲ +157.1%
  3. Amazon 2.0%▲ +68.2%
  4. Microsoft 1.6%▼ −19.6%
  5. Arista Networks 1.6%▲ +37.2%
  6. Broadcom 1.6%▲ +80.0%
  7. Credo Technology Group 1.3%▲ +17.5%
  8. ASML Holding (ADR) 1.0%▲ +33.0%
  9. Sea Limited (ADR) 1.0%▲ +194.7%
  10. Coherent Corp. 1.0%▼ −14.4%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q4 2025

Positions Q4 2025 per 13F filing, 50 of 327
Symbol Weight Shares Reported value Change Held since
DD DuPont < 0.1% 1,074,606 43.2M USD −36.5% reduced Q2 2019 27 quarters
Bicycle Therapeutics PLC < 0.1% 76,779 543.6K USD −82.2% reduced Q4 2019 25 quarters
GM General Motors < 0.1% 166,503 13.5M USD −68.9% reduced Q2 2020 23 quarters
Uniqure NV < 0.1% 24,439 584.8K USD −90.4% reduced Q2 2020 23 quarters
Post HLDGS Inc < 0.1% 82,655 8.2M USD −71.7% reduced Q4 2020 21 quarters
Dyne Therapeutics Inc < 0.1% 329,345 6.4M USD −80.8% reduced Q1 2021 20 quarters
Bath & Body Works Inc < 0.1% 1,873,211 37.6M USD −9.7% reduced Q3 2021 18 quarters
Stoneco Ltd 0.2% 6,325,122 93.5M USD −16.5% reduced Q4 2021 17 quarters
Hertz Global HLDGS Inc < 0.1% 1,113,413 5.7M USD −44.1% reduced Q4 2021 17 quarters
Pagseguro Digital Ltd < 0.1% 5,911,693 57.0M USD −41.3% reduced Q1 2022 16 quarters
Webster Finl Corp < 0.1% 647,058 40.7M USD −20.7% reduced Q1 2022 16 quarters
Axsome Therapeutics Inc < 0.1% 17,999 3.3M USD −3.8% reduced Q2 2022 15 quarters
Celldex Therapeutics Inc New < 0.1% 1,758,357 47.8M USD −54.8% reduced Q3 2022 14 quarters
ISRG Intuitive Surgical 0.5% 582,819 330.1M USD −4.9% reduced Q4 2022 13 quarters
KDP Keurig Dr Pepper 0.3% 6,341,111 177.6M USD −10.4% reduced Q4 2022 13 quarters
AMT American Tower < 0.1% 77,849 13.7M USD −87.4% reduced Q4 2022 13 quarters
Burlington Stores Inc < 0.1% 176,820 51.1M USD −26.6% reduced Q1 2023 12 quarters
Cnh Indl N V < 0.1% 3,332,191 30.7M USD −24.3% reduced Q1 2023 12 quarters
Cogent Biosciences Inc < 0.1% 827,525 29.4M USD −33.1% reduced Q1 2023 12 quarters
Topbuild Corp < 0.1% 40,149 16.7M USD −15.3% reduced Q1 2023 12 quarters
WAB Wabtec < 0.1% 45,956 9.8M USD −88.9% reduced Q1 2023 12 quarters
RAPID7 Inc < 0.1% 443,655 6.7M USD −5.3% reduced Q1 2023 12 quarters
Maxlinear Inc < 0.1% 78,359 1.4M USD −84.4% reduced Q1 2023 12 quarters
COHR Coherent Corp. 1.0% 3,338,935 616.3M USD −14.4% reduced Q2 2023 11 quarters
Arcus Biosciences Inc 0.1% 3,280,000 78.2M USD −24.3% reduced Q2 2023 11 quarters
VTR Ventas < 0.1% 176,334 13.6M USD −32.7% reduced Q2 2023 11 quarters
Foghorn Therapeutics Inc < 0.1% 61,968 334.6K USD −83.3% reduced Q2 2023 11 quarters
JD JD.com (ADR) < 0.1% 1,268,925 36.4M USD −76.0% reduced Q3 2023 10 quarters
Natera Inc < 0.1% 125,312 28.7M USD −47.6% reduced Q3 2023 10 quarters
CRH CRH plc < 0.1% 180,376 22.5M USD −46.5% reduced Q3 2023 10 quarters
MOS Mosaic Company (The) < 0.1% 666,965 16.1M USD −41.2% reduced Q3 2023 10 quarters
Parsons Corp Del < 0.1% 255,198 15.8M USD −14.8% reduced Q3 2023 10 quarters
Methanex Corp < 0.1% 290,812 11.6M USD 0.0% reduced Q3 2023 10 quarters
Abivax SA 0.5% 2,409,154 324.9M USD −17.6% reduced Q4 2023 9 quarters
Tower Semiconductor Ltd 0.3% 1,613,540 189.5M USD −42.9% reduced Q4 2023 9 quarters
Repligen Corp 0.3% 1,006,310 164.9M USD −30.2% reduced Q4 2023 9 quarters
Praxis Precision Medicines I 0.2% 492,346 145.1M USD −67.1% reduced Q4 2023 9 quarters
Ishares TR 0.2% 1,878,500 99.3M USD −22.8% reduced Q4 2023 9 quarters
Teladoc Health Inc < 0.1% 5,661,322 39.6M USD −1.8% reduced Q4 2023 9 quarters
ROST Ross Stores 0.3% 1,001,565 180.4M USD −0.6% reduced Q1 2024 8 quarters
SPDR Series Trust 0.2% 3,480,000 117.7M USD −14.1% reduced Q1 2024 8 quarters
Macom Tech Solutions HLDGS I 0.2% 551,641 94.5M USD −4.1% reduced Q1 2024 8 quarters
ZBRA Zebra Technologies 0.1% 302,353 73.4M USD −48.0% reduced Q1 2024 8 quarters
Dianthus Therapeutics Inc < 0.1% 1,166,088 48.1M USD −42.9% reduced Q1 2024 8 quarters
SHIFT4 Pmts Inc < 0.1% 740,956 46.7M USD −51.5% reduced Q1 2024 8 quarters
Icon PLC < 0.1% 194,150 35.4M USD −58.0% reduced Q1 2024 8 quarters
Jbt Marel Corporation < 0.1% 217,202 32.7M USD −47.9% reduced Q1 2024 8 quarters
Wesco Intl Inc < 0.1% 106,910 26.2M USD −29.1% reduced Q1 2024 8 quarters
Cg Oncology Inc < 0.1% 151,363 6.3M USD −90.1% reduced Q1 2024 8 quarters
Engene Holdings Inc < 0.1% 561,797 5.1M USD −53.5% reduced Q1 2024 8 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 327 positions.

Plus 1745 option positions, value of the underlying shares as reported 25.6B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 1.7B USD
  • Invesco QQQ TR Put 1.3B USD
  • SPDR S&P 500 ETF TR Call 1.2B USD
  • SPDR Series Trust Put 498.5M USD
  • Ishares TR Put 431.5M USD
  • SPDR Gold TR Put 252.0M USD
  • Johnson & Johnson Put 185.8M USD
  • Biogen Call 176.3M USD
  • Invesco QQQ TR Call 169.1M USD
  • Strategy (MicroStrategy) Call 163.1M USD
Plus 87 positions in convertible bonds and bonds worth 2.7B USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Wec Energy Group Inc principal 136.3M USD 154.0M USD
  • Centerpoint Energy Inc principal 126.6M USD 138.5M USD
  • Post HLDGS Inc principal 126.8M USD 136.7M USD
  • Evergy Inc principal 100.0M USD 121.7M USD
  • Ford Mtr Co principal 101.5M USD 105.3M USD
  • Ugi Corp New principal 72.1M USD 102.4M USD
  • Strategy Inc principal 70.0M USD 88.8M USD
  • Applied Digital Corp principal 30.3M USD 82.0M USD
  • Alliant Energy Corp principal 77.5M USD 80.6M USD
  • The Realreal Inc principal 46.2M USD 78.5M USD

Breakdown by sector

  • Technology 21.0%
  • Health Care 5.5%
  • Financials 5.2%
  • Consumer Discretionary 5.2%
  • Industrials 4.2%
  • Utilities 2.6%
  • Consumer Staples 2.2%
  • Communication Services 2.0%
  • Energy 1.5%
  • Real Estate 1.4%
  • Materials 1.0%
  • not in our coverage 48.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close